Medacta Group SA

As of December 31, 2025, Medacta Group SA carries a market capitalization of 3.11B, placing it among publicly traded companies globally. Its enterprise value stands at 3.33B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Medacta Group SA's next confirmed earnings release is scheduled for March 12, 2027.

As of December 31, 2025, Medacta Group SA has 19.91M shares outstanding.

These figures are as of December 31, 2025.

As of December 31, 2025, Medacta Group SA maintains a current ratio of 2.08, meaning it holds 2.1x the short-term assets needed to cover near-term liabilities.

These figures cover the twelve months ended December 31, 2025.

As of the close on October 22, 2026, Medacta Group SA's stock has declined approximately 21.38% over the past 52 weeks. The 50-day moving average sits at 119.38, while the 200-day moving average is 140.37.

As of December 31, 2025, Medacta Group SA holds 30.92M in cash and equivalents against 242.77M in total debt, resulting in a net debt position of 158.02M. Total book value stands at 425.08M, with working capital of 217.23M providing operational flexibility.